A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias.
about
A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma.Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort studyInternational reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine.Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis.Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study.Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysisPrognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies.The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment.Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data.Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma.Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.Physical Fitness Among Swedish Military Conscripts and Long-Term Risk for Type 2 Diabetes Mellitus: A Cohort Study.Challenges of guarantee-time biasTreatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.Diabetes, metformin, and breast cancer in postmenopausal womenWomen's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapySuggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.Survival probabilities with time-dependent treatment indicator: quantities and non-parametric estimators.Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study.Systemic inflammatory response syndrome after pediatric congenital heart surgery: Incidence, risk factors, and clinical outcome.Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma.Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes.Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm.Using multiple timescale models for the evaluation of a time-dependent treatment.Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry.Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.Current aspects of drug therapy in Philadelphia-positive CML: correlation of tumor burden with survival.A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial.
P2860
Q33402536-A4DDB99C-AC42-477F-AFD9-67D1B05F78C2Q33710753-58EA1389-7E54-4137-ACEB-6ABDE0CEDDD1Q33750223-B945BC49-CB3A-4102-A2E8-0368CE2D7B59Q33822004-60151672-A225-4F1E-A700-D8D400E8DF7CQ34088756-FA1092D5-19F6-4706-81FA-02D5B52A6445Q35553389-C8D66695-02DE-4C95-8448-A13155AFA0E0Q35653306-417CF093-464B-44D3-8294-22B5A02EB2E2Q35847158-46FD6503-AFED-46CC-9266-7429AB5CA986Q35984291-078D706D-99E9-490F-98CF-2CBD70A8E458Q36002325-AA888A1E-345E-4AED-B9DB-B98A8CB16D46Q36261529-01BCEBE0-0309-4B81-A77E-52C00668891EQ36350443-6A518A6C-971D-424F-80E9-4CCDD2A351A0Q36356861-6F29A98B-03DE-4BE0-AE2F-E5B5A2C807C5Q36608664-ED855E05-F548-4AC1-9951-AFC887236FC3Q36650103-FC6D4AAF-26D6-43D3-AD18-6A78F0E96F8EQ36750458-48BA0B31-E6C3-4AAA-B6A7-15B4DBCB963FQ36883424-FA783DC2-B9B3-48A8-A7DC-5480FC13032BQ37066734-D26AB066-93D3-4B26-985D-A79BEF90A061Q37130218-8EA9E899-CAFD-4D3F-8841-F67B6C5AA51FQ37252283-86CC7E5E-5045-44EA-B184-8465F6DAA71DQ37303867-7F913D98-EC37-4ED3-9B36-1245B525F1DDQ37315529-0424D483-DED3-4792-8707-6A5B7AE854B3Q38086718-A33BBCEA-8055-4D4D-9D32-4E2F9690C07DQ38270640-730A66D3-592B-4E1B-A980-151F1EE57C32Q38616796-AFB3EE16-E6CF-4BCE-BF62-52AB1F1626B6Q38709053-A622928D-AB2D-4D3B-AE7C-681A20AD0BD7Q39029165-F8841F30-3ABB-4E8F-BDDF-2DFF0CCC5EC7Q39120987-D664DF4E-549E-428A-BAB3-33B97DC906A4Q39283573-437269D9-61DF-464D-A304-AE232F5BDA1BQ39597202-A63D6917-B1F8-452F-8168-2A946B7A0482Q39739502-3A2B0D77-02A0-40EC-888D-0A917C34B847Q40466623-A3758085-E74C-4E3B-99E4-1697EA447EABQ40469080-59725688-ADF5-4793-B894-0A41426ECC47Q40501623-E41A15E3-EDEF-4BBB-8DC2-C378BAE67EFCQ40690585-F20BD5B6-7713-4DBF-BEDB-77C9841578E1Q40845932-BE0DF3AC-0B13-49D1-89A2-91E2A520CD69Q40974681-050AD179-FF2C-43DB-A11F-A048F277A30CQ41195564-264F7309-58DD-4A91-A3D3-C74D0054A4F9Q41253203-2143712E-B8A1-4E0E-80C8-E185711155B1Q41471081-E077A8D5-3F5C-4185-B1A4-50544C3178F0
P2860
A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
A non-parametric graphical rep ...... der versus non-responder bias.
@en
type
label
A non-parametric graphical rep ...... der versus non-responder bias.
@en
prefLabel
A non-parametric graphical rep ...... der versus non-responder bias.
@en
P356
P1476
A non-parametric graphical rep ...... der versus non-responder bias.
@en
P2093
P356
10.1002/SIM.4780030106
P407
P577
1984-01-01T00:00:00Z